ORMP
Price
$2.23
Change
+$0.01 (+0.45%)
Updated
Sep 5 closing price
Capitalization
91.44M
69 days until earnings call
PRLD
Price
$1.23
Change
+$0.09 (+7.89%)
Updated
Sep 5 closing price
Capitalization
69.62M
73 days until earnings call
Interact to see
Advertisement

ORMP vs PRLD

Header iconORMP vs PRLD Comparison
Open Charts ORMP vs PRLDBanner chart's image
Oramed Pharmaceuticals
Price$2.23
Change+$0.01 (+0.45%)
Volume$58.88K
Capitalization91.44M
Prelude Therapeutics
Price$1.23
Change+$0.09 (+7.89%)
Volume$90.66K
Capitalization69.62M
ORMP vs PRLD Comparison Chart in %
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. PRLD commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a StrongBuy and PRLD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ORMP: $2.23 vs. PRLD: $1.23)
Brand notoriety: ORMP and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 83% vs. PRLD: 56%
Market capitalization -- ORMP: $91.44M vs. PRLD: $69.62M
ORMP [@Biotechnology] is valued at $91.44M. PRLD’s [@Biotechnology] market capitalization is $69.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRLD is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 5 TA indicator(s) are bullish while PRLD’s TA Score has 6 bullish TA indicator(s).

  • ORMP’s TA Score: 5 bullish, 3 bearish.
  • PRLD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ORMP and PRLD are a good buy in the short-term.

Price Growth

ORMP (@Biotechnology) experienced а +1.36% price change this week, while PRLD (@Biotechnology) price change was +1.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ORMP is expected to report earnings on Nov 14, 2025.

PRLD is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($91.4M) has a higher market cap than PRLD($69.6M). PRLD YTD gains are higher at: -3.529 vs. ORMP (-7.851). ORMP has higher annual earnings (EBITDA): -22.07M vs. PRLD (-133.25M). ORMP has more cash in the bank: 97.9M vs. PRLD (73.2M). ORMP has less debt than PRLD: ORMP (912K) vs PRLD (17.9M). PRLD has higher revenues than ORMP: PRLD (7M) vs ORMP (2M).
ORMPPRLDORMP / PRLD
Capitalization91.4M69.6M131%
EBITDA-22.07M-133.25M17%
Gain YTD-7.851-3.529222%
P/E Ratio20.91N/A-
Revenue2M7M29%
Total Cash97.9M73.2M134%
Total Debt912K17.9M5%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
47
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORMPPRLD
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 10 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPPMF0.170.01
+5.17%
Coppernico Metals Inc
FNCSF5.370.05
+0.94%
North American Financial 15 Split Corp
WHGRF1.07N/A
+0.10%
WH Group Ltd.
SRKE0.20N/A
N/A
Strake Inc.
VLEEF12.25N/A
N/A
Valeo SE

ORMP and

Correlation & Price change

A.I.dvisor tells us that ORMP and VALN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORMP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.45%
VALN - ORMP
29%
Poorly correlated
-2.15%
FULC - ORMP
28%
Poorly correlated
+11.34%
BCAB - ORMP
28%
Poorly correlated
+7.54%
PRLD - ORMP
27%
Poorly correlated
+7.89%
SONN - ORMP
27%
Poorly correlated
-1.72%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with ATNM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+7.89%
ATNM - PRLD
38%
Loosely correlated
-6.51%
ITOS - PRLD
32%
Poorly correlated
N/A
HUMA - PRLD
31%
Poorly correlated
-2.05%
FDMT - PRLD
31%
Poorly correlated
+9.98%
DSGN - PRLD
30%
Poorly correlated
+5.56%
More